300 related articles for article (PubMed ID: 10584769)
1. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
[TBL] [Abstract][Full Text] [Related]
2. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
Melkersson KI; Hulting AL
Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
[TBL] [Abstract][Full Text] [Related]
3. The effect of clozapine on factors controlling glucose homeostasis.
Howes OD; Gaughran FP; Amiel SA; Murray RM; Pilowsky LS
J Clin Psychiatry; 2004 Oct; 65(10):1352-5. PubMed ID: 15491238
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035
[TBL] [Abstract][Full Text] [Related]
5. [Antipsychotic drugs can affect hormone balance. Weight gain, blood lipid disturbances and diabetes are important].
Melkersson K; Hulting AL
Lakartidningen; 2001 Nov; 98(48):5462-4, 5467-9. PubMed ID: 11769361
[TBL] [Abstract][Full Text] [Related]
6. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
[TBL] [Abstract][Full Text] [Related]
7. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
8. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
Melkersson K; Berinder K; Hulting AL
Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
[TBL] [Abstract][Full Text] [Related]
10. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.
Melkersson KI; Dahl ML
Psychopharmacology (Berl); 2003 Nov; 170(2):157-66. PubMed ID: 12851739
[TBL] [Abstract][Full Text] [Related]
11. Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Liu ZN; Zhai JG; Guo XF; Guo WB; Tang JS
Psychopharmacology (Berl); 2006 Jul; 186(4):572-8. PubMed ID: 16601995
[TBL] [Abstract][Full Text] [Related]
12. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Rane AJ
Br J Clin Pharmacol; 2001 Apr; 51(4):317-24. PubMed ID: 11318766
[TBL] [Abstract][Full Text] [Related]
13. Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
Rettenbacher MA; Hummer M; Hofer A; Baumgartner S; Ebenbichler C; Edlinger M; Kemmler G; Lechleitner M; Wolfgang Fleischhacker W
J Psychopharmacol; 2007 Jun; 21(4):400-4. PubMed ID: 17050656
[TBL] [Abstract][Full Text] [Related]
14. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
[TBL] [Abstract][Full Text] [Related]
15. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
[TBL] [Abstract][Full Text] [Related]
16. The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients.
Howes OD; Smith S; Gaughran FP; Amiel SA; Murray RM; Pilowsky LS
J Clin Psychopharmacol; 2006 Dec; 26(6):629-31. PubMed ID: 17110820
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics and glucose homeostasis.
Bergman RN; Ader M
J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
[TBL] [Abstract][Full Text] [Related]
18. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Melkersson K; Lewitt M; Hall K
Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
[TBL] [Abstract][Full Text] [Related]
19. Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy.
Wysokiński A
Diabetes Metab Syndr; 2014; 8(4):236-41. PubMed ID: 25311817
[TBL] [Abstract][Full Text] [Related]
20. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
